Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Slee

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Acta Medica Scandinavica|January 1, 1979
A case of merbromin (Mercurochrome) intoxication possibly resulting in aplastic anemiaP H Slee, G J den Ottolander, F A de Wolff
Pharmaceutisch Weekblad. Scientific Edition|June 21, 1985
Predictive testing in cancer chemotherapy. I. In vivoP H Slee, A T Van Oosterom, E A De Bruijn
Pharmaceutisch Weekblad. Scientific Edition|August 23, 1985
Predictive testing in cancer chemotherapy. II. In vitroP H Slee, A T Van Oosterom, E A De Bruijn
International Journal of Cancer|March 1, 1996
Preferential location of circulating activated cyclophosphamide within the erythrocyteM S Highley, P G Harper, P H Slee, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levelsD de Vos, P H Slee, R J Briggs, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancerD de Vos, P H Slee, D Stevenson, et al.
Postgraduate Medical Journal|November 1, 1996
Intravenous leiomyomatosis complicated by Budd-Chiari syndromeB C Kuenen, P H Slee, C A Seldenrijk, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 26, 1994
[Chemotherapy in metastasized breast carcinoma: intermittent or continuous?]J W Nortier, C J Rodenburg, P H Slee, et al.
Human Mutation|October 3, 2000
A novel mutation (1653insC) in the thyroid hormone receptor beta in a patient resistant to thyroid hormoneY Y van der Hoek, M W Mul-Steinbusch, P H Slee
Nederlands Tijdschrift Voor Geneeskunde|June 27, 1992
[Hypercalcemia and malignancies; pathogenesis, differential diagnosis and treatment]P H Slee, H P Koppeschaar, J W Nortier, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Acta Medica Scandinavica|January 1, 1979
A case of merbromin (Mercurochrome) intoxication possibly resulting in aplastic anemiaP H Slee, G J den Ottolander, F A de Wolff
Pharmaceutisch Weekblad. Scientific Edition|June 21, 1985
Predictive testing in cancer chemotherapy. I. In vivoP H Slee, A T Van Oosterom, E A De Bruijn
Pharmaceutisch Weekblad. Scientific Edition|August 23, 1985
Predictive testing in cancer chemotherapy. II. In vitroP H Slee, A T Van Oosterom, E A De Bruijn
International Journal of Cancer|March 1, 1996
Preferential location of circulating activated cyclophosphamide within the erythrocyteM S Highley, P G Harper, P H Slee, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levelsD de Vos, P H Slee, R J Briggs, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancerD de Vos, P H Slee, D Stevenson, et al.
Postgraduate Medical Journal|November 1, 1996
Intravenous leiomyomatosis complicated by Budd-Chiari syndromeB C Kuenen, P H Slee, C A Seldenrijk, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 26, 1994
[Chemotherapy in metastasized breast carcinoma: intermittent or continuous?]J W Nortier, C J Rodenburg, P H Slee, et al.
Human Mutation|October 3, 2000
A novel mutation (1653insC) in the thyroid hormone receptor beta in a patient resistant to thyroid hormoneY Y van der Hoek, M W Mul-Steinbusch, P H Slee
Nederlands Tijdschrift Voor Geneeskunde|June 27, 1992
[Hypercalcemia and malignancies; pathogenesis, differential diagnosis and treatment]P H Slee, H P Koppeschaar, J W Nortier, et al.
Pageof 6